Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Cardiovascular Disease and COVID-19 Vaccines
Author(s): Abdulrhman Khaity , Ala’ Abdala Mohamad Rababah , Omar A Abdelwahab , et al Added: 1 year ago

COVID-19

CV Disease in Special Populations
NF-kB in Cardiovascular Disease
Author(s): Akira Matsumori Added: 1 year ago

Vascular Disease and Surgery

Imaging & Diagnostics
Pre-eclampsia and CVD
Author(s): Veronica Giorgione , Matthew Cauldwell , Basky Thilaganathan Added: 1 year ago

Demographic

Prevention & Chronic Conditions
ESC 23: Economic Burden of CVD in the EU
Author(s): Ramón Luengo-Fernández Added: 1 year ago
ESC 2023 — Dr Ramón Luengo-Fernández (University of Oxford, UK) joins us on-site to discuss the findings from a registry which aimed to analyse the economic burden of cardiovascular disease within the EU. This was the first study to utilise Europe-wide patient registries and included the costs of long-term social care. Results from the registry found that cardiovascular disease cost the EU €282… View more

Guidelines & Statements
Author(s): Evan A Stein Added: 1 year ago
ACC.24 — We are joined onsite by investigator, Dr Evan A Stein (Medpace Reference Laboratories, US) to discuss the findings from the LIBerate-CVD trial (NCT04797247).LIBerate-CVD investigated LDL-C reductions in a cohort of 900 patients with cardiovascular diseases and hyper-LDL-cholesterol treated with 300mg subcutaneous Lerodalcibep as compared to placebo across a 52-week treatment period… View more

Prevention & Chronic Conditions
Cardiovascular Disease and Type 2 Diabetes
Author(s): Martin Berger , Nikolaus Marx , Katharina Marx-Schütt Added: 3 weeks ago

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Remnant Lipoproteins and ASCVD
Author(s): Mohanad Gabani , Michael D Shapiro , Peter P Toth Added: 1 year ago

Prevention & Chronic Conditions
Cardiovascular Risk in NAFLD
Author(s): Paula Luque-Linero , Luis Castilla-Guerra Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Apabetalone: Evidence and Outcomes Related to Cardiovascular Health
Author(s): Yimeng Zhang , Nimai Desai , Derek Connolly Added: 2 months ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Cardiovascular Effects of NSAIDs: A Review With a Focus on RA Patients
Author(s): Eirik Ikdahl , Anne Kerola , Eli Sollerud , et al Added: 4 months ago

Prevention & Chronic Conditions